Editas Medicine (EDIT) FCF Margin Growth (5y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -32,508.00 |
| Jun 30, 2025 | -109,917.00 |
| Mar 31, 2025 | -4,595.00 |
| Dec 31, 2024 | -50,348.00 |
| Sep 30, 2024 | -9.02 Mn |
| Jun 30, 2024 | -1.07 Mn |
| Mar 31, 2024 | -313,986.00 |
| Dec 31, 2023 | -9,825.00 |
| Sep 30, 2023 | -65,005.00 |
| Jun 30, 2023 | -105,422.00 |
| Mar 31, 2023 | 19,345.00 |
| Sep 30, 2022 | -12.25 Mn |
| Jun 30, 2022 | -193,740.00 |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | 160,629.00 |
| Sep 30, 2021 | 92,770.00 |
| Jun 30, 2021 | -1.02 Mn |
| Mar 31, 2021 | 49,887.00 |
| Dec 31, 2020 | 71,280.00 |
| Sep 30, 2020 | 172,815.00 |
| Jun 30, 2020 | -1.21 Mn |